Endocrinology
From the Journals
Atypical fractures with bisphosphonates highest in Asians, study confirms
The benefits of bisphosphonates in fracture reduction still far outweigh risks for atypical femur fractures, but the study shows a higher risk for...
Latest News
Humira topped drug-revenue list for 2019
Three cytokine inhibitors were among the four best-selling drugs last year.
From the Journals
Evidence mounts for COVID-19 effects on thyroid gland
Among severely ill patients with COVID-19, rates of thyrotoxicosis are significantly higher than among patients without it. But those with thyroid...
From the Journals
Does metformin reduce risk for death in COVID-19?
“It is still unclear whether metformin is truly a miracle drug or whether it is simply used more often among people who are healthier and who do...
Guidelines
Guidance covers glycemia in dexamethasone-treated COVID-19 patients
The latest document from the COVID-19 response group of the Association of British Clinical Diabetologists is a response to the recent RECOVERY...
From the Journals
Diabetic amputations soared amid Italian pandemic lockdown
Gangrene cases also skyrocketed, suggesting that patients failed to get proper care during national shutdown.
Feature
Telemedicine meets menopause in customized patient care service
New portal allows patients access to experts on perimenopause and menopause through a membership plan.
Feature
SGLT2 inhibitors have a breakout year
From the Journals
Fracture risk prediction: No benefit to repeat BMD testing in postmenopausal women
But experts advise against a broad recommendation to skip repeat testing in the general population.
From the Journals
Unexpected rosuvastatin-canagliflozin adverse effect reported
From the Journals
COVID-19 taking financial toll on people in U.S. with diabetes
Unemployment and income loss caused by the pandemic are higher among those with diabetes than in the general U.S. population.